BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17255342)

  • 1. Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis.
    Kojima T; Chang JH; Azar DT
    Am J Pathol; 2007 Feb; 170(2):764-73. PubMed ID: 17255342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas.
    Kojima T; Chung TY; Chang JH; Sayegh R; Casanova FH; Azar DT
    Cornea; 2007 Jun; 26(5):569-78. PubMed ID: 17525654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphrinB-mediated reverse signalling controls junctional integrity and pro-inflammatory differentiation of endothelial cells.
    Liu H; Devraj K; Möller K; Liebner S; Hecker M; Korff T
    Thromb Haemost; 2014 Jul; 112(1):151-63. PubMed ID: 24522257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.
    Adams RH; Wilkinson GA; Weiss C; Diella F; Gale NW; Deutsch U; Risau W; Klein R
    Genes Dev; 1999 Feb; 13(3):295-306. PubMed ID: 9990854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization.
    Onguchi T; Han KY; Chang JH; Azar DT
    Am J Pathol; 2009 Apr; 174(4):1564-71. PubMed ID: 19264910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system.
    Zhang J; Hughes S
    J Pathol; 2006 Mar; 208(4):453-61. PubMed ID: 16470907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy.
    Schmidt JF; Agapova OA; Yang P; Kaufman PL; Hernandez MR
    Br J Ophthalmol; 2007 Sep; 91(9):1219-24. PubMed ID: 17301119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis.
    Huynh-Do U; Vindis C; Liu H; Cerretti DP; McGrew JT; Enriquez M; Chen J; Daniel TO
    J Cell Sci; 2002 Aug; 115(Pt 15):3073-81. PubMed ID: 12118063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal endothelial modulation: a factor released by leukocytes induces basic fibroblast growth factor that modulates cell shape and collagen.
    Kay EP; Gu X; Ninomiya Y; Smith RE
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):663-72. PubMed ID: 8449685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.
    Prevost N; Woulfe D; Tanaka T; Brass LF
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9219-24. PubMed ID: 12084815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of angiogenesis by Eph-ephrin interactions.
    Kuijper S; Turner CJ; Adams RH
    Trends Cardiovasc Med; 2007 Jul; 17(5):145-51. PubMed ID: 17574121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis.
    Han KY; Chang JH; Lee H; Azar DT
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3313-22. PubMed ID: 27327585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF Trap(R1R2) suppresses experimental corneal angiogenesis.
    Oliveira HB; Sakimoto T; Javier JA; Azar DT; Wiegand SJ; Jain S; Chang JH
    Eur J Ophthalmol; 2010; 20(1):48-54. PubMed ID: 19882518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization.
    Liu G; Zhang W; Xiao Y; Lu P
    Curr Eye Res; 2015 Sep; 40(9):891-901. PubMed ID: 25309995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P
    Lopez ES; Ortiz GA; Potilinski C; Croxatto JO; Gallo JE
    Curr Eye Res; 2018 Apr; 43(4):466-473. PubMed ID: 29265937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of corneal neovascularization by rapamycin.
    Kwon YS; Kim JC
    Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of EphrinB1 expression in prostatic mesenchyme and a role for EphB-EphrinB signalling in prostate development.
    Ashley GR; Grace OC; Vanpoucke G; Thomson AA
    Differentiation; 2010; 80(2-3):89-98. PubMed ID: 20633976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.